Shanghai Pharmaceuticals Holding (601607.SH): Isavuconazonium Sulfate for Injection Approved for Production
Shanghai Pharmaceuticals Holding (601607.SH) announced that recently, its subsidiary Shanghai Pharma Dongying (Jiangsu) Pharmaceutical Co., Ltd. (hereinafter referred to as "Shanghai Pharma Dongying") received the Drug Registration Certificate (Certificate No.: 2026S03379) issued by the National Medical Products Administration (hereinafter referred to as the "NMPA") for Isavuconazonium Sulfate for Injection (hereinafter referred to as "the drug"), and the drug has been approved for production. Isavuconazonium Sulfate for Injection is indicated for the treatment of the following infections in adults and pediatric patients 1 year of age and older: invasive aspergillosis and invasive mucormycosis.
Shanghai Pharmaceuticals Holding (601607.SH) announced that recently, its subsidiary Shanghai Pharma Dongying (Jiangsu) Pharmaceutical Co., Ltd. (hereinafter referred to as "Shanghai Pharma Dongying") received the Drug Registration Certificate (Certificate No.: 2026S03379) issued by the National Medical Products Administration (hereinafter referred to as the "NMPA") for Isavuconazonium Sulfate for Injection (hereinafter referred to as "the drug"), and the drug was approved for production. Isavuconazonium Sulfate for Injection is indicated for the treatment of the following infections in adults and pediatric patients 1 year of age and older: invasive aspergillosis and invasive mucormycosis.
Related Articles
GREENTOWN SER (02869) repurchased 230,000 shares for approximately HK$950,800 on September 28.
ES SERVICES (01995) repurchased 200,000 shares for HK$340,000 on September 28.
HUABAO INTL (00336): Members of the Group have separately subscribed for financial products from the Bank Of Jiangsu Group and the Bank Of Nanjing.
GREENTOWN SER (02869) repurchased 230,000 shares for approximately HK$950,800 on September 28.
ES SERVICES (01995) repurchased 200,000 shares for HK$340,000 on September 28.
HUABAO INTL (00336): Members of the Group have separately subscribed for financial products from the Bank Of Jiangsu Group and the Bank Of Nanjing.
